Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Medtronic issues 'Class I' recall for HeartWare HVAD pump outflow graft » 13:03
05/28/20
05/28
13:03
05/28/20
13:03
MDT

Medtronic

$99.31 /

+3.31 (+3.45%)

Medtronic is recalling…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MDT Medtronic
$99.31 /

+3.31 (+3.45%)

MDT Medtronic
$99.31 /

+3.31 (+3.45%)

05/26/20 SunTrust
Medtronic price target lowered to $105 from $130 at SunTrust
05/21/20 Piper Sandler
Medtronic price target lowered to $120 from $135 at Piper Sandler
05/21/20 Piper Sandler
Medtronic robot delay positive for Intuitive Surgical, says Piper Sandler
05/14/20 DZ Bank
Medtronic downgraded to Hold from Buy at DZ Bank
MDT Medtronic
$99.31 /

+3.31 (+3.45%)

MDT Medtronic
$99.31 /

+3.31 (+3.45%)

MDT Medtronic
$99.31 /

+3.31 (+3.45%)

MDT Medtronic
$99.31 /

+3.31 (+3.45%)

Tuesday
General News
White House statement on President's action to protect seniors with diabetes » 17:33
05/26/20
05/26
17:33
05/26/20
17:33
DXCM

DexCom

$381.60 /

-23.55 (-5.81%)

, TNDM

TNDM

/

+

, MDT

Medtronic

$97.15 /

+2.44 (+2.58%)

, NVO

Novo Nordisk

$63.36 /

-1.5 (-2.31%)

, JNJ

Johnson & Johnson

$144.48 /

+0.11 (+0.08%)

, LLY

Eli Lilly

$147.88 /

-3.27 (-2.16%)

, SNY

Sanofi

$47.26 /

-0.05 (-0.11%)

The White House said, in…

The White House said, in part, on the press call, on the President's action to protect seniors with diabetes: "To give you a sense of the scope of what that means: Roughly one in three Medicare beneficiaries has diabetes, and millions use one or more of the common forms of insulin. Seniors who sign up for these new plans will have no more than a 35-dollar co-pay for a month's supply of all types of insulin. That results in approximately a 66 percent, or two-thirds, reduction in out-of-pocket costs. The result: For the third year in a row, the average basic premium for Medicare Part D prescription drug prices has declined, saving beneficiaries $1.9 billion in premiums over time. Three years into the Trump administration, third consecutive year that these Medicare Part D premiums have declined. That's called causation, not coincidence. We continue to deliver creative solutions that result in historic agreements." Companies that may be impacted by this announcement include DexCom (DXCM), Tandem Diabetes (TNDM), Medtronic (MDT) Novo Nordisk (NVO), Johnson & Johnson (JNJ), Eli Lilly (LLY) and Sanofi (SNY). Reference Link

ShowHide Related Items >><<
TNDM TNDM
/

+

SNY Sanofi
$47.26 /

-0.05 (-0.11%)

NVO Novo Nordisk
$63.36 /

-1.5 (-2.31%)

MDT Medtronic
$97.15 /

+2.44 (+2.58%)

LLY Eli Lilly
$147.88 /

-3.27 (-2.16%)

JNJ Johnson & Johnson
$144.48 /

+0.11 (+0.08%)

DXCM DexCom
$381.60 /

-23.55 (-5.81%)

DXCM DexCom
$381.60 /

-23.55 (-5.81%)

05/14/20 Wells Fargo
DexCom initiated with an Equal Weight at Wells Fargo
04/29/20 Stifel
DexCom price target raised to $385 from $270 at Stifel
04/29/20 Oppenheimer
DexCom price target raised to $360 from $305 at Oppenheimer
04/29/20 Cowen
DexCom price target raised to $360 from $300 at Cowen
TNDM TNDM
/

+

04/27/20 Guggenheim
Guggenheim ups DexCom target, concerned about Tandem Diabetes
04/24/20 SVB Leerink
Tandem Diabetes downgraded to Market Perform from Outperform at SVB Leerink
04/24/20 SVB Leerink
Tandem Diabetes downgraded to Market Perform from Outperform at SVB Leerink
04/20/20 Craig-Hallum
Tandem Diabetes price target lowered to $102 from $108 at Craig-Hallum
MDT Medtronic
$97.15 /

+2.44 (+2.58%)

05/26/20 SunTrust
Medtronic price target lowered to $105 from $130 at SunTrust
05/21/20 Piper Sandler
Medtronic price target lowered to $120 from $135 at Piper Sandler
05/21/20 Piper Sandler
Medtronic robot delay positive for Intuitive Surgical, says Piper Sandler
05/14/20 DZ Bank
Medtronic downgraded to Hold from Buy at DZ Bank
NVO Novo Nordisk
$63.36 /

-1.5 (-2.31%)

05/18/20 Morgan Stanley
Novo Nordisk price target raised to DKK 435 from DKK 425 at Morgan Stanley
05/13/20 JPMorgan
Novo Nordisk price target raised to DKK 480 from DKK 460 at JPMorgan
05/11/20
Fly Intel: Top five analyst downgrades
05/11/20 UBS
Novo Nordisk downgraded to Neutral from Buy at UBS
JNJ Johnson & Johnson
$144.48 /

+0.11 (+0.08%)

05/12/20 Oppenheimer
Novavax price target raised to $38.50 from $19 at Oppenheimer
04/29/20 Stephens
Catalent deal with J&J could represent $600M revenue opportunity, says Stephens
04/29/20 Barclays
Johnson & Johnson price target raised to $182 from $173 at Barclays
04/28/20 UBS
Johnson & Johnson downgraded to Neutral from Buy at UBS
LLY Eli Lilly
$147.88 /

-3.27 (-2.16%)

04/24/20 Cantor Fitzgerald
Eli Lilly price target raised to $185 from $156 at Cantor Fitzgerald
04/24/20 Mizuho
Eli Lilly price target raised to $155 from $148 at Mizuho
04/21/20
Fly Intel: Top five analyst downgrades
04/21/20 UBS
Eli Lilly downgraded to Neutral from Buy at UBS
SNY Sanofi
$47.26 /

-0.05 (-0.11%)

05/26/20 UBS
Sanofi price target lowered to EUR 101 from EUR 103 at UBS
05/26/20 Piper Sandler
Piper remains buyer of Regeneron, ups target to $630 on buyback accretion
05/26/20 SVB Leerink
Sanofi overhang removed, Regeneron capital structure improving, says SVB Leerink
TNDM TNDM
/

+

SNY Sanofi
$47.26 /

-0.05 (-0.11%)

NVO Novo Nordisk
$63.36 /

-1.5 (-2.31%)

MDT Medtronic
$97.15 /

+2.44 (+2.58%)

LLY Eli Lilly
$147.88 /

-3.27 (-2.16%)

JNJ Johnson & Johnson
$144.48 /

+0.11 (+0.08%)

DXCM DexCom
$381.60 /

-23.55 (-5.81%)

SNY Sanofi
$47.26 /

-0.05 (-0.11%)

NVO Novo Nordisk
$63.36 /

-1.5 (-2.31%)

MDT Medtronic
$97.15 /

+2.44 (+2.58%)

LLY Eli Lilly
$147.88 /

-3.27 (-2.16%)

JNJ Johnson & Johnson
$144.48 /

+0.11 (+0.08%)

DXCM DexCom
$381.60 /

-23.55 (-5.81%)

TNDM TNDM
/

+

SNY Sanofi
$47.26 /

-0.05 (-0.11%)

NVO Novo Nordisk
$63.36 /

-1.5 (-2.31%)

MDT Medtronic
$97.15 /

+2.44 (+2.58%)

LLY Eli Lilly
$147.88 /

-3.27 (-2.16%)

JNJ Johnson & Johnson
$144.48 /

+0.11 (+0.08%)

DXCM DexCom
$381.60 /

-23.55 (-5.81%)

TNDM TNDM
/

+

SNY Sanofi
$47.26 /

-0.05 (-0.11%)

MDT Medtronic
$97.15 /

+2.44 (+2.58%)

JNJ Johnson & Johnson
$144.48 /

+0.11 (+0.08%)

Recommendations
Medtronic price target lowered to $105 from $130 at SunTrust » 09:25
05/26/20
05/26
09:25
05/26/20
09:25
MDT

Medtronic

$94.71 /

-0.67 (-0.70%)

SunTrust analyst Kaila…

SunTrust analyst Kaila Krum lowered the firm's price target on Medtronic to $105 from $130 but keeps a Buy rating on the shares after its Q4 earnings miss and outlook given last week. The analyst also lowers her FY21 EPS view to $2.40 from $6.06, but believes that the investments the company is making today will have a long-term positive growth impact.

ShowHide Related Items >><<
MDT Medtronic
$94.71 /

-0.67 (-0.70%)

MDT Medtronic
$94.71 /

-0.67 (-0.70%)

05/21/20 Piper Sandler
Medtronic price target lowered to $120 from $135 at Piper Sandler
05/21/20 Piper Sandler
Medtronic robot delay positive for Intuitive Surgical, says Piper Sandler
05/14/20 DZ Bank
Medtronic downgraded to Hold from Buy at DZ Bank
04/28/20 Piper Sandler
Untreated heart attacks negative for Abiomed, says Piper Sandler
MDT Medtronic
$94.71 /

-0.67 (-0.70%)

MDT Medtronic
$94.71 /

-0.67 (-0.70%)

MDT Medtronic
$94.71 /

-0.67 (-0.70%)

MDT Medtronic
$94.71 /

-0.67 (-0.70%)

Friday
Hot Stocks
Medtronic CEO says U.S. business has seen 'snapback' in recent weeks » 11:44
05/22/20
05/22
11:44
05/22/20
11:44
MDT

Medtronic

$93.00 /

-2.38 (-2.50%)

Medtronic CEO Geoff…

Medtronic CEO Geoff Martha said on CNBC that while it's too early to extrapolate out, the company's U.S. business has seen a "snapback" in recent weakness. Medtronic's business in China is seeing a slower recovery trajectory, Martha added.

ShowHide Related Items >><<
MDT Medtronic
$93.00 /

-2.38 (-2.50%)

MDT Medtronic
$93.00 /

-2.38 (-2.50%)

05/21/20 Piper Sandler
Medtronic price target lowered to $120 from $135 at Piper Sandler
05/21/20 Piper Sandler
Medtronic robot delay positive for Intuitive Surgical, says Piper Sandler
05/14/20 DZ Bank
Medtronic downgraded to Hold from Buy at DZ Bank
04/28/20 Piper Sandler
Untreated heart attacks negative for Abiomed, says Piper Sandler
MDT Medtronic
$93.00 /

-2.38 (-2.50%)

MDT Medtronic
$93.00 /

-2.38 (-2.50%)

MDT Medtronic
$93.00 /

-2.38 (-2.50%)

MDT Medtronic
$93.00 /

-2.38 (-2.50%)

Hot Stocks
Medtronic says Guardian Connect GCM system now compatible with Androids » 09:05
05/22/20
05/22
09:05
05/22/20
09:05
MDT

Medtronic

$95.38 /

-2.66 (-2.71%)

Medtronic announced U.S.…

Medtronic announced U.S. Food and Drug Administration approval for the Android version of its Guardian Connect continuous glucose monitoring system. The Guardian Connect system is a standalone CGM system that alerts patients of potential high or low sensor glucose events up to 60 minutes in advance and provides confidence to people living with diabetes who worry about fluctuating glucose levels and dangerous low glucose events. The Guardian Connect app will include several enhancements to further improve user experience. These include easier product setup through the in-app Startup Wizard, and personalized volume adjustments, including the ability to mute alerts when individuals do not want to be disturbed for a period of time. The Guardian Connect system leverages the Guardian Sensor 3, the most advanced glucose sensor from Medtronic, to accurately alert users of lows more than 90% of the time so users can feel confident in the numbers they are seeing. Through the company's latest predictive algorithms, the Guardian Connect system is also the only standalone CGM system that can alert patients of potential high or low sensor glucose events up to 60 minutes in advance, allowing individuals time to plan and take action if necessary. The updated Guardian Connect system with Android compatibility is expected to begin shipping in summer of this year. Existing Guardian Connect customers will also be contacted this summer about the update and how they can update their app to receive the latest functionality.

ShowHide Related Items >><<
MDT Medtronic
$95.38 /

-2.66 (-2.71%)

MDT Medtronic
$95.38 /

-2.66 (-2.71%)

05/21/20 Piper Sandler
Medtronic price target lowered to $120 from $135 at Piper Sandler
05/21/20 Piper Sandler
Medtronic robot delay positive for Intuitive Surgical, says Piper Sandler
05/14/20 DZ Bank
Medtronic downgraded to Hold from Buy at DZ Bank
04/28/20 Piper Sandler
Untreated heart attacks negative for Abiomed, says Piper Sandler
MDT Medtronic
$95.38 /

-2.66 (-2.71%)

MDT Medtronic
$95.38 /

-2.66 (-2.71%)

MDT Medtronic
$95.38 /

-2.66 (-2.71%)

MDT Medtronic
$95.38 /

-2.66 (-2.71%)

Over a week ago
Recommendations
Medtronic price target lowered to $120 from $135 at Piper Sandler » 20:56
05/21/20
05/21
20:56
05/21/20
20:56
MDT

Medtronic

$95.38 /

-2.66 (-2.71%)

Piper Sandler analyst…

Piper Sandler analyst Matt O'Brien lowered the firm's price target on Medtronic to $120 from $135 but keeps an Overweight rating on the shares. The company's Q4 results were weak due to the impact of Covid-19 and Q1 is expected to be even worse from revenue contraction perspective, the analyst tells investors in a research note. O'Brien adds that the potentially longer than expected delays to 780G and the surgical robot were key negatives from Medtronic's earnings call, though the management's commentary seeking to implement programs to bolster position with hospital customers may "benefit the company significantly."

ShowHide Related Items >><<
MDT Medtronic
$95.38 /

-2.66 (-2.71%)

MDT Medtronic
$95.38 /

-2.66 (-2.71%)

05/21/20 Piper Sandler
Medtronic robot delay positive for Intuitive Surgical, says Piper Sandler
05/14/20 DZ Bank
Medtronic downgraded to Hold from Buy at DZ Bank
04/28/20 Piper Sandler
Untreated heart attacks negative for Abiomed, says Piper Sandler
04/22/20 Wells Fargo
Medtronic price target lowered to $108 from $130 at Wells Fargo
MDT Medtronic
$95.38 /

-2.66 (-2.71%)

MDT Medtronic
$95.38 /

-2.66 (-2.71%)

MDT Medtronic
$95.38 /

-2.66 (-2.71%)

MDT Medtronic
$95.38 /

-2.66 (-2.71%)

Recommendations
Medtronic robot delay positive for Intuitive Surgical, says Piper Sandler » 11:34
05/21/20
05/21
11:34
05/21/20
11:34
ISRG

Intuitive Surgical

/

+

, MDT

Medtronic

$95.60 /

-2.44 (-2.49%)

Medtronic (MDT), when…

Medtronic (MDT), when reporting fiscal Q4 results today, said its ability to complete required software system and pre-clinical testing for its surgical robot has been delayed due to COVID-19, Piper Sandler analyst Adam Maeder tells investors in a research note. The analyst, who believes the Medtronic surgical robot system could be delayed by roughly two quarters, views today's update as an "incremental positive" for Intuitive Surgical (ISRG). Intuitive is well positioned from a competitive standpoint and any material delays to new market entrants could further strengthen its first-mover advantage, contends Maeder. The analyst, however, keeps a Neutral rating on the shares with a $510 price target citing a lack of visibility on new system placements and valuation.

ShowHide Related Items >><<
MDT Medtronic
$95.60 /

-2.44 (-2.49%)

ISRG Intuitive Surgical
/

+

ISRG Intuitive Surgical
/

+

04/29/20 Piper Sandler
Intuitive Surgical estimates lowered on support program at Piper Sandler
04/28/20
Fly Intel: Top five analyst downgrades
04/28/20 Piper Sandler
Intuitive Surgical downgraded to Neutral from Overweight at Piper Sandler
04/17/20 Deutsche Bank
Intuitive Surgical price target lowered to $500 from $595 at Deutsche Bank
MDT Medtronic
$95.60 /

-2.44 (-2.49%)

05/14/20 DZ Bank
Medtronic downgraded to Hold from Buy at DZ Bank
04/28/20 Piper Sandler
Untreated heart attacks negative for Abiomed, says Piper Sandler
04/22/20 Wells Fargo
Medtronic price target lowered to $108 from $130 at Wells Fargo
04/09/20 Raymond James
Medtronic price target lowered to $110 from $122 at Raymond James
MDT Medtronic
$95.60 /

-2.44 (-2.49%)

ISRG Intuitive Surgical
/

+

MDT Medtronic
$95.60 /

-2.44 (-2.49%)

ISRG Intuitive Surgical
/

+

MDT Medtronic
$95.60 /

-2.44 (-2.49%)

ISRG Intuitive Surgical
/

+

MDT Medtronic
$95.60 /

-2.44 (-2.49%)

ISRG Intuitive Surgical
/

+

On The Fly
Fly Intel: Pre-market Movers » 09:16
05/21/20
05/21
09:16
05/21/20
09:16
KDMN

Kadmon

$4.38 /

+0.01 (+0.23%)

, TGP

Teekay LNG

$11.70 /

+0.66 (+5.98%)

, TNK

Teekay Tankers

$16.08 /

+0.4 (+2.55%)

, BJ

BJ's Wholesale

$28.98 /

+0.52 (+1.83%)

, EXPE

Expedia

$79.64 /

+3.26 (+4.27%)

, HRL

Hormel Foods

$48.00 /

+0.61 (+1.29%)

, MDT

Medtronic

$98.04 /

+0.94 (+0.97%)

, BBY

Best Buy

$81.35 /

-2.145 (-2.57%)

, TJX

TJX

$50.81 /

+0.52 (+1.03%)

, TTWO

Take-Two

$146.99 /

+4.73 (+3.32%)

, BSX

Boston Scientific

$37.19 /

+1.78 (+5.03%)

Check out this morning's…

Open Full Text

ShowHide Related Items >><<
TTWO Take-Two
$146.99 /

+4.73 (+3.32%)

TNK Teekay Tankers
$16.08 /

+0.4 (+2.55%)

TJX TJX
$50.81 /

+0.52 (+1.03%)

TGP Teekay LNG
$11.70 /

+0.66 (+5.98%)

MDT Medtronic
$98.04 /

+0.94 (+0.97%)

KDMN Kadmon
$4.38 /

+0.01 (+0.23%)

HRL Hormel Foods
$48.00 /

+0.61 (+1.29%)

EXPE Expedia
$79.64 /

+3.26 (+4.27%)

BSX Boston Scientific
$37.19 /

+1.78 (+5.03%)

BJ BJ's Wholesale
$28.98 /

+0.52 (+1.83%)

BBY Best Buy
$81.35 /

-2.145 (-2.57%)

KDMN Kadmon
$4.38 /

+0.01 (+0.23%)

05/19/20 Raymond James
Kadmon initiated with an Outperform at Raymond Jame
05/19/20 Raymond James
Kadmon initiated with an Outperform at Raymond James
03/16/20 Nomura Instinet
Kadmon news of FDA meeting a positive, says Nomura Instinet
01/10/20 Nomura Instinet
Kadmon initiated with a Buy at Nomura Instinet
TGP Teekay LNG
$11.70 /

+0.66 (+5.98%)

10/02/19
Teekay Corp. Investor Day has been postponed
TNK Teekay Tankers
$16.08 /

+0.4 (+2.55%)

03/09/20 DNB Markets
Teekay Tankers downgraded to Hold from Buy at DNB Markets
11/18/19 BofA
Teekay Tankers upgraded two notches to Buy from Underperform at BofA/Merrill
11/18/19 BofA
Teekay Tankers upgraded to Buy from Underperform at BofA/Merrill
10/23/19 Jefferies
Jefferies upgrades Teekay Tankers to Buy, boosts target to $2.50 from $1.50
BJ BJ's Wholesale
$28.98 /

+0.52 (+1.83%)

05/14/20 Credit Suisse
BJ's Wholesale price target raised to $31 from $26 at Credit Suisse
05/01/20 JPMorgan
Ulta Beauty, BJ's best near-term picks in retail, says JPMorgan
04/15/20 Citi
BJ's Wholesale assumed with a Neutral from Buy at Citi
04/14/20 Loop Capital
BJ's Wholesale price target raised to $35 from $30 at Loop Capital
EXPE Expedia
$79.64 /

+3.26 (+4.27%)

05/21/20 Credit Suisse
Expedia price target raised to $101 from $90 at Credit Suisse
05/21/20 Deutsche Bank
Expedia price target raised to $112 from $87 at Deutsche Bank
05/21/20 Benchmark
Expedia price target lowered to $103 from $155 at Benchmark
05/21/20 RBC Capital
Expedia price target raised to $90 from $71 at RBC Capital
HRL Hormel Foods
$48.00 /

+0.61 (+1.29%)

04/29/20
Fly Intel: Top five analyst downgrades
04/29/20 Piper Sandler
Hormel downgraded to Neutral on foodservice risk at Piper Sandler
04/28/20 Piper Sandler
Hormel Foods downgraded to Neutral from Overweight at Piper Sandler
03/26/20
Fly Intel: Top five analyst upgrades
MDT Medtronic
$98.04 /

+0.94 (+0.97%)

05/14/20 DZ Bank
Medtronic downgraded to Hold from Buy at DZ Bank
04/28/20 Piper Sandler
Untreated heart attacks negative for Abiomed, says Piper Sandler
04/22/20 Wells Fargo
Medtronic price target lowered to $108 from $130 at Wells Fargo
04/09/20 Raymond James
Medtronic price target lowered to $110 from $122 at Raymond James
BBY Best Buy
$81.35 /

-2.145 (-2.57%)

05/18/20
Fly Intel: Top five analyst upgrades
05/18/20 Telsey Advisory
Best Buy upgraded to Outperform from Market Perform at Telsey Advisory
05/14/20
Fly Intel: Top five analyst upgrades
05/14/20 Wells Fargo
Best Buy price target raised to $75 from $60 at Wells Fargo
TJX TJX
$50.81 /

+0.52 (+1.03%)

05/19/20 Jefferies
TJX to benefit from 'biggest liquidation sale in history,' says Jefferies
05/11/20 Nomura Instinet
TJX price target raised to $59 from $56 at Nomura Instinet
05/04/20 Barclays
TJX price target lowered to $60 from $74 at Barclays
04/29/20
Fly Intel: Top five analyst upgrades
TTWO Take-Two
$146.99 /

+4.73 (+3.32%)

05/21/20 Wedbush
Take-Two price target raised to $170 from $131 at Wedbush
05/21/20 MKM Partners
Take-Two price target raised to $145 from $124 at MKM Partners
05/21/20 Oppenheimer
Take-Two price target raised to $155 from $145 at Oppenheimer
05/21/20 Morgan Stanley
Take-Two price target raised to $150 from $140 at Morgan Stanley
BSX Boston Scientific
$37.19 /

+1.78 (+5.03%)

05/10/20 Piper Sandler
FLX to further strengthen Boston category leadership in LAAC, says Piper Sandler
04/22/20 SVB Leerink
Boston Scientific downgraded to Market Perform at SVB Leerink on slower recovery
04/22/20 SVB Leerink
Boston Scientific downgraded to Market Perform from Outperform at SVB Leerink
TTWO Take-Two
$146.99 /

+4.73 (+3.32%)

TNK Teekay Tankers
$16.08 /

+0.4 (+2.55%)

TJX TJX
$50.81 /

+0.52 (+1.03%)

TGP Teekay LNG
$11.70 /

+0.66 (+5.98%)

MDT Medtronic
$98.04 /

+0.94 (+0.97%)

KDMN Kadmon
$4.38 /

+0.01 (+0.23%)

HRL Hormel Foods
$48.00 /

+0.61 (+1.29%)

EXPE Expedia
$79.64 /

+3.26 (+4.27%)

BSX Boston Scientific
$37.19 /

+1.78 (+5.03%)

BJ BJ's Wholesale
$28.98 /

+0.52 (+1.83%)

BBY Best Buy
$81.35 /

-2.145 (-2.57%)

  • 22
    May
TTWO Take-Two
$146.99 /

+4.73 (+3.32%)

TJX TJX
$50.81 /

+0.52 (+1.03%)

MDT Medtronic
$98.04 /

+0.94 (+0.97%)

HRL Hormel Foods
$48.00 /

+0.61 (+1.29%)

EXPE Expedia
$79.64 /

+3.26 (+4.27%)

BSX Boston Scientific
$37.19 /

+1.78 (+5.03%)

BJ BJ's Wholesale
$28.98 /

+0.52 (+1.83%)

BBY Best Buy
$81.35 /

-2.145 (-2.57%)

TTWO Take-Two
$146.99 /

+4.73 (+3.32%)

TJX TJX
$50.81 /

+0.52 (+1.03%)

MDT Medtronic
$98.04 /

+0.94 (+0.97%)

HRL Hormel Foods
$48.00 /

+0.61 (+1.29%)

EXPE Expedia
$79.64 /

+3.26 (+4.27%)

BJ BJ's Wholesale
$28.98 /

+0.52 (+1.83%)

BBY Best Buy
$81.35 /

-2.145 (-2.57%)

TTWO Take-Two
$146.99 /

+4.73 (+3.32%)

TJX TJX
$50.81 /

+0.52 (+1.03%)

MDT Medtronic
$98.04 /

+0.94 (+0.97%)

HRL Hormel Foods
$48.00 /

+0.61 (+1.29%)

EXPE Expedia
$79.64 /

+3.26 (+4.27%)

BSX Boston Scientific
$37.19 /

+1.78 (+5.03%)

BBY Best Buy
$81.35 /

-2.145 (-2.57%)

Hot Stocks
Medtronic seeing early signs of recovery, sees Q1 as 'trough'  08:47
05/21/20
05/21
08:47
05/21/20
08:47
MDT

Medtronic

$98.04 /

+0.94 (+0.97%)

 
ShowHide Related Items >><<
MDT Medtronic
$98.04 /

+0.94 (+0.97%)

MDT Medtronic
$98.04 /

+0.94 (+0.97%)

05/14/20 DZ Bank
Medtronic downgraded to Hold from Buy at DZ Bank
04/28/20 Piper Sandler
Untreated heart attacks negative for Abiomed, says Piper Sandler
04/22/20 Wells Fargo
Medtronic price target lowered to $108 from $130 at Wells Fargo
04/09/20 Raymond James
Medtronic price target lowered to $110 from $122 at Raymond James
MDT Medtronic
$98.04 /

+0.94 (+0.97%)

MDT Medtronic
$98.04 /

+0.94 (+0.97%)

MDT Medtronic
$98.04 /

+0.94 (+0.97%)

MDT Medtronic
$98.04 /

+0.94 (+0.97%)

Hot Stocks
Medtronic won't buy growth, would do tuck-in M&A  08:42
05/21/20
05/21
08:42
05/21/20
08:42
MDT

Medtronic

$98.04 /

+0.94 (+0.97%)

 
ShowHide Related Items >><<
MDT Medtronic
$98.04 /

+0.94 (+0.97%)

MDT Medtronic
$98.04 /

+0.94 (+0.97%)

05/14/20 DZ Bank
Medtronic downgraded to Hold from Buy at DZ Bank
04/28/20 Piper Sandler
Untreated heart attacks negative for Abiomed, says Piper Sandler
04/22/20 Wells Fargo
Medtronic price target lowered to $108 from $130 at Wells Fargo
04/09/20 Raymond James
Medtronic price target lowered to $110 from $122 at Raymond James
MDT Medtronic
$98.04 /

+0.94 (+0.97%)

MDT Medtronic
$98.04 /

+0.94 (+0.97%)

MDT Medtronic
$98.04 /

+0.94 (+0.97%)

MDT Medtronic
$98.04 /

+0.94 (+0.97%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.